Center of Experimental Orthopaedics, Saarland University, Kirrberger Straße 100, Building 37, D-66421, Homburg, Germany.
Fidia Farmaceutici S.p.A., Via Ponte della Fabbrica 3/A, Abano Terme (PD), 35031, Italy.
Adv Healthc Mater. 2023 Oct;12(26):e2300931. doi: 10.1002/adhm.202300931. Epub 2023 Aug 18.
Articular cartilage defects represent an unsolved clinical challenge. Photopolymerizable hydrogels are attractive candidates supporting repair. This study investigates the short-term safety and efficacy of two novel hyaluronic acid (HA)-triethylene glycol (TEG)-coumarin hydrogels photocrosslinked in situ in a clinically relevant large animal model. It is hypothesized that HA-hydrogel-augmented microfracture (MFX) is superior to MFX in enhancing early cartilage repair, and that the molar degree of substitution and concentration of HA affects repair. Chondral full-thickness defects in the knees of adult minipigs are treated with either 1) debridement (No MFX), 2) debridement and MFX, 3) debridement, MFX, and HA hydrogel (30% molar derivatization, 30 mg mL HA; F3) (MFX+F3), and 4) debridement, MFX, and HA hydrogel (40% molar derivatization, 20 mg mL HA; F4) (MFX+F4). After 8 weeks postoperatively, MFX+F3 significantly improves total macroscopic and histological scores compared with all other groups without negative effects, besides significantly enhancing the individual repair parameters "defect architecture," "repair tissue surface" (compared with No MFX, MFX), and "subchondral bone" (compared with MFX). These data indicate that photopolymerizable HA hydrogels enable a favorable metastable microenvironment promoting early chondrogenesis in vivo. This work also uncovers a mechanism for effective HA-augmented cartilage repair by combining lower molar derivatization with higher concentrations.
关节软骨缺损是一个尚未解决的临床难题。光聚合水凝胶是一种有吸引力的候选材料,可用于支持修复。本研究旨在临床相关的大型动物模型中,研究两种新型透明质酸(HA)-三乙二醇(TEG)-香豆素光交联原位水凝胶的短期安全性和疗效。假设 HA 水凝胶增强微骨折(MFX)在增强早期软骨修复方面优于 MFX,并且 HA 的摩尔取代度和浓度影响修复。成年小型猪膝关节的软骨全层缺损分别采用以下方法治疗:1)清创(无 MFX),2)清创和 MFX,3)清创、MFX 和 HA 水凝胶(30%摩尔衍生化,30mg/mL HA;F3)(MFX+F3),和 4)清创、MFX 和 HA 水凝胶(40%摩尔衍生化,20mg/mL HA;F4)(MFX+F4)。术后 8 周,与其他组相比,MFX+F3 组的总宏观和组织学评分显著提高,且无不良反应,除了显著提高了“缺损结构”、“修复组织表面”(与无 MFX 和 MFX 相比)和“软骨下骨”(与 MFX 相比)等个别修复参数。这些数据表明,光聚合透明质酸水凝胶能够在体内产生有利的亚稳微环境,促进早期软骨发生。这项工作还揭示了通过结合较低的摩尔衍生化和较高的浓度来增强 HA 增强软骨修复的机制。